Skip to main content
Top
Published in: BMC Cancer 1/2005

Open Access 01-12-2005 | Research article

Breast conserving surgery versus mastectomy: cancer practice by general surgeons in Iran

Authors: Massoome Najafi, Mandana Ebrahimi, Ahmad Kaviani, Esmat Hashemi, Ali Montazeri

Published in: BMC Cancer | Issue 1/2005

Login to get access

Abstract

Background

There appear to be geographical differences in decisions to perform mastectomy or breast conserving surgery for early-stage breast cancer. This study was carried out to evaluate general surgeons' preferences in breast cancer surgery and to assess the factors predicting cancer practice in Iran.

Methods

A structured questionnaire was mailed to 235 general surgeons chosen from the address list of the Iranian Medical Council. The questionnaire elicited information about the general surgeons' characteristics and about their work experience, posts they have held, number of breast cancer operations performed per year, preferences for mastectomy or breast conserving surgery, and the reasons for these preferences.

Results

In all, 83 surgeons returned the completed questionnaire. The results indicated that only 19% of the surgeons routinely performed breast conserving surgery (BCS) and this was significantly associated with their breast cancer case load (P < 0.01). There were no associations between BCS practice and the other variables studied. The most frequent reasons for not performing BCS were uncertainty about conservative therapy results (46%), uncertainty about the quality of available radiotherapy services (32%), and the probability of patients' non-compliance in radiotherapy (32%).

Conclusion

The findings indicate that Iranian surgeons do not routinely perform BCS as the first and the best treatment modality. Further research is recommended to evaluate patients' outcomes after BCS treatment in Iran, with regard to available radiotherapy facilities and cultural factors (patients' compliance).
Literature
1.
go back to reference Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, del Vecchio M, Mariani L, Zurrida S, Rilke F: Breast conservation is a safe method in patients with small cancer of the breast. Long term results of three randomized trials on 1,973 patients. Eur J Cancer. 1995, 31A: 1574-1579. 10.1016/0959-8049(95)00271-J.CrossRefPubMed Veronesi U, Salvadori B, Luini A, Greco M, Saccozzi R, del Vecchio M, Mariani L, Zurrida S, Rilke F: Breast conservation is a safe method in patients with small cancer of the breast. Long term results of three randomized trials on 1,973 patients. Eur J Cancer. 1995, 31A: 1574-1579. 10.1016/0959-8049(95)00271-J.CrossRefPubMed
2.
go back to reference Arriagada R, Le MG, Rochard F, Contesso G: Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institute Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996, 14: 1558-1564.PubMed Arriagada R, Le MG, Rochard F, Contesso G: Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institute Gustave-Roussy Breast Cancer Group. J Clin Oncol. 1996, 14: 1558-1564.PubMed
3.
go back to reference Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995, 333: 1456-1461. 10.1056/NEJM199511303332203.CrossRefPubMed Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995, 333: 1456-1461. 10.1056/NEJM199511303332203.CrossRefPubMed
4.
go back to reference Jacobson JA, Danforth DN, Cowan KH, d'Angelo T, Steinberg SM, Pierce L, Lippman ME, Lichter AS, Glatstein E, Okunieff P: Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995, 332: 907-911. 10.1056/NEJM199504063321402.CrossRefPubMed Jacobson JA, Danforth DN, Cowan KH, d'Angelo T, Steinberg SM, Pierce L, Lippman ME, Lichter AS, Glatstein E, Okunieff P: Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995, 332: 907-911. 10.1056/NEJM199504063321402.CrossRefPubMed
5.
go back to reference NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA. 1991, 265: 391-395. 10.1001/jama.265.3.391. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA. 1991, 265: 391-395. 10.1001/jama.265.3.391.
6.
go back to reference Mousavi R, Akbari ME: Epidemiologic study of breast diseases in Isfahan. PhD thesis. 1993, Isfahan University of Medical Sciences, Department of Surgery Mousavi R, Akbari ME: Epidemiologic study of breast diseases in Isfahan. PhD thesis. 1993, Isfahan University of Medical Sciences, Department of Surgery
7.
go back to reference Atai Fashtami H, Atri M: A retrospective study of 350 cases of breast cancer: histological type, sex, stage, treatment and the results of 10 year follow-up. PhD thesis. 1994, Tehran University of Medical Sciences, Department of Surgery Atai Fashtami H, Atri M: A retrospective study of 350 cases of breast cancer: histological type, sex, stage, treatment and the results of 10 year follow-up. PhD thesis. 1994, Tehran University of Medical Sciences, Department of Surgery
8.
go back to reference Kotwall CA, Maxwell JG, Covington DL, Churchill P, Smith SE, Covan EK: Clinicopathologic factors and patient perceptions associated with surgical breast-conserving treatment. Ann Surg Oncol. 1996, 3: 169-175.CrossRefPubMed Kotwall CA, Maxwell JG, Covington DL, Churchill P, Smith SE, Covan EK: Clinicopathologic factors and patient perceptions associated with surgical breast-conserving treatment. Ann Surg Oncol. 1996, 3: 169-175.CrossRefPubMed
9.
go back to reference Van Donegan JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Winter J, van Zijl K: Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer: EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992, 11: 15-18. Van Donegan JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Winter J, van Zijl K: Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer: EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992, 11: 15-18.
10.
go back to reference Harris JR, Lippman ME, Morrow M, Osborne CK: Disease of the breast. 2000, Lippincot Williams & Wilkins, 2 Harris JR, Lippman ME, Morrow M, Osborne CK: Disease of the breast. 2000, Lippincot Williams & Wilkins, 2
11.
go back to reference Weinberg E, Woods S, Grannan K, Hendy MP: The influence of the gender of the surgeon on surgical procedure preference for breast cancer. Am Surg. 2002, 68: 398-400.PubMed Weinberg E, Woods S, Grannan K, Hendy MP: The influence of the gender of the surgeon on surgical procedure preference for breast cancer. Am Surg. 2002, 68: 398-400.PubMed
12.
go back to reference Kotwall C, Covington D, Churchill P, Brinker C, Weintritt D, Maxwell JG: Breast conservation surgery for breast cancer at a regional medical center. Am J Surg. 1998, 176: 510-514. 10.1016/S0002-9610(98)00254-2.CrossRefPubMed Kotwall C, Covington D, Churchill P, Brinker C, Weintritt D, Maxwell JG: Breast conservation surgery for breast cancer at a regional medical center. Am J Surg. 1998, 176: 510-514. 10.1016/S0002-9610(98)00254-2.CrossRefPubMed
13.
go back to reference Kotwall CA, Covington DL, Rutledge R, Churchill MP, Meyer AA: Patient, hospital and surgeon factors associated with breast conservation surgery. A statewide analysis in North Carolina. Ann Surg. 1996, 224: 419-426. 10.1097/00000658-199610000-00001.CrossRefPubMedPubMedCentral Kotwall CA, Covington DL, Rutledge R, Churchill MP, Meyer AA: Patient, hospital and surgeon factors associated with breast conservation surgery. A statewide analysis in North Carolina. Ann Surg. 1996, 224: 419-426. 10.1097/00000658-199610000-00001.CrossRefPubMedPubMedCentral
14.
go back to reference Taylor R, Stubbs JM, Langlands AO, Boyages J: Predictors of mastectomy for women with breast cancer in greater western region of Sydney. Breast J. 1999, 5: 116-121. 10.1046/j.1524-4741.1999.00135.x.CrossRefPubMed Taylor R, Stubbs JM, Langlands AO, Boyages J: Predictors of mastectomy for women with breast cancer in greater western region of Sydney. Breast J. 1999, 5: 116-121. 10.1046/j.1524-4741.1999.00135.x.CrossRefPubMed
15.
go back to reference Stafford D, Szczys R, Becker R, Anderson J, Bushfield S: How breast cancer treatment decisions are made by women in North Dakota. Am J Surg. 1997, 176: 515-519. 10.1016/S0002-9610(98)00257-8.CrossRef Stafford D, Szczys R, Becker R, Anderson J, Bushfield S: How breast cancer treatment decisions are made by women in North Dakota. Am J Surg. 1997, 176: 515-519. 10.1016/S0002-9610(98)00257-8.CrossRef
Metadata
Title
Breast conserving surgery versus mastectomy: cancer practice by general surgeons in Iran
Authors
Massoome Najafi
Mandana Ebrahimi
Ahmad Kaviani
Esmat Hashemi
Ali Montazeri
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2005
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-5-35

Other articles of this Issue 1/2005

BMC Cancer 1/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine